Literature DB >> 27250982

Early Detection of Steatohepatitis: Less Teeth NASHing and More Research?

Emmanuel Thomas1, Eugene R Schiff2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27250982     DOI： 10.1007/s10620-016-4201-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

1.  Statin use and reduced cancer-related mortality.

Authors:  Sune F Nielsen; Børge G Nordestgaard; Stig E Bojesen
Journal:  N Engl J Med       Date:  2012-11-08       Impact factor: 91.245

Review 2.  Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

Review 3.  Perspectives on Treatment for Nonalcoholic Steatohepatitis.

Authors:  Guillaume Lassailly; Robert Caiazzo; François Pattou; Philippe Mathurin
Journal:  Gastroenterology       Date:  2016-03-10       Impact factor: 22.682

4.  Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.

Authors:  Sajan Jiv Singh Nagpal; Mohammad Nasser Kabbany; Bashar Mohamad; Rocio Lopez; Nizar N Zein; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

5.  Practice patterns in NAFLD and NASH: real life differs from published guidelines.

Authors:  Mary E Rinella; Zurabi Lominadze; Rohit Loomba; Michael Charlton; Brent A Neuschwander-Tetri; Stephen H Caldwell; Kris Kowdley; Stephen A Harrison
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

6.  Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.

Authors:  L B VanWagner; M Serper; R Kang; J Levitsky; S Hohmann; M Abecassis; A Skaro; D M Lloyd-Jones
Journal:  Am J Transplant       Date:  2016-03-29       Impact factor: 8.086

Review 7.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

8.  Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.

Authors:  Petra Hirsova; Samar H Ibrahim; Anuradha Krishnan; Vikas K Verma; Steven F Bronk; Nathan W Werneburg; Michael R Charlton; Vijay H Shah; Harmeet Malhi; Gregory J Gores
Journal:  Gastroenterology       Date:  2016-01-05       Impact factor: 22.682

9.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.